Cargando…
Global metabolomic profiling of uterine leiomyomas
BACKGROUND: Uterine leiomyomas can be classified into molecularly distinct subtypes according to their genetic triggers: MED12 mutations, HMGA2 upregulation, or inactivation of FH. The aim of this study was to identify metabolites and metabolic pathways that are dysregulated in different subtypes of...
Autores principales: | Heinonen, Hanna-Riikka, Mehine, Miika, Mäkinen, Netta, Pasanen, Annukka, Pitkänen, Esa, Karhu, Auli, Sarvilinna, Nanna S, Sjöberg, Jari, Heikinheimo, Oskari, Bützow, Ralf, Aaltonen, Lauri A, Kaasinen, Eevi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729474/ https://www.ncbi.nlm.nih.gov/pubmed/29073636 http://dx.doi.org/10.1038/bjc.2017.361 |
Ejemplares similares
-
Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas
por: Heinonen, Hanna-Riikka, et al.
Publicado: (2017) -
MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas
por: Kämpjärvi, Kati, et al.
Publicado: (2016) -
Genetic predisposition to uterine leiomyoma is determined by loci for genitourinary development and genome stability
por: Välimäki, Niko, et al.
Publicado: (2018) -
Parity associates with chromosomal damage in uterine leiomyomas
por: Kuisma, Heli, et al.
Publicado: (2021) -
Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate
por: Kolterud, Åsa, et al.
Publicado: (2022)